November 14th 2023
We’ve compiled a list of key food safety tips that you need to know in order to have a safe, bacteria-free holiday.
September 8th 2022
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Initial Safety Surveillance on Shingrix Consistent With Clinical Trial Data
February 6th 2019Post-licensure safety data on recombinant zoster vaccine (Shingrix) is consistent with pre-licensure clinical trial data, although the CDC cautions that the immunization is still in the “early uptake period.”
Read More
Playing the Long Game: Documented Penicillin Allergies Require Follow-up
January 18th 2019A large percentage of individuals with a documented allergy to penicillin can actually be treated safely with this class of antibiotics. It just requires careful evaluation and management on the part of health care providers.
Read More
Survey Explores How Behavioral Model May Help Increase PrEP Use in At-Risk Groups
January 5th 2019While the United States has seen significant increases in pre-exposure prophylaxis (PrEP) use among those at risk for HIV infection, PrEP uptake rates are still low overall in men who have sex with men, as well as in transgender individuals. A new study examines how a behavior model may help increase PrEP use in these at-risk groups.
Read More
PrEP Is Approved for Adolescents: Why Isn't it Being Prescribed More?
January 4th 2019When taken consistently, PrEP can reduce the risk of HIV infection by 92%. So why aren’t more health care professionals prescribing it to adolescents, who continue to have an increased HIV incidence rate nationally?
Read More
Metronidazole Comparable to Vancomycin for Mild C Diff Infections
December 26th 2018In a new study, researchers with the US Department of Veterans Affairs found that metronidazole is as effective as vancomycin for treating mild cases of Clostridium difficile infection, despite new guidelines no longer recommending metronidazole.
Read More
A Look Into the Antimicrobial Stewardship Collaborative of South Carolina
December 17th 2018Providers in other states can learn from this multiorganization collaborative that aims to improve antimicrobial utilization and prevent the emergence of antimicrobial resistance across South Carolina.
Read More